21 May 2009
Influence of viral infections on allografts function and acute graft rejection (agr) in both donors and recipients
P Jurkowski, A Mikłaszewicz, M Cićkiewicz, P Orszulak, M Fiedor, Z Lewandowski, P FiedorAnn Transplant 2009; 14(1): 74-74 :: ID: 880471
Abstract
Background: Virus infections play a key role and directly influence allograft
function in recipients under chronic immunosuppression. The aim of this study was to evaluate the infl uence of CMV, EBV, HBV and HCV virus infections in both donors and recipients on graft stability.
Material/Methods: The medical histories of 171 kidney and liver allograft recipients were analyzed in search of viral infections. Next, every recipient was matched with their donors. It was evaluated how different viral infections influence the time of acute graft rejection.
Results: There was no significant difference in the time of acute rejection time between HBVAg positive and HBVAg negative recipients (p>0.05). Seven months after transplantation, the number of Anti-HCV positive recipients after AGR was twice as big as the number of Anti-HCV negative patients (p=0.0176). Seven months after transplantation, the number of CMV-IgM positive recipients after AGR was three times as big as the number of CMV-IgM negative patients(p=0.0292). There was found no correlation between EBV infection and acute rejection time.
Conclusions: Our data strongly indicate that both HCV and CMV virus infections worsen allograft stability in transplant recipients and immunosuppression is an independent risk factor.
Keywords: CMV infections, HBV infection, HCV infection, viral infections
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860